EXPLORE!

Vitamin C in prophylaxis and adjunctive treatment of COVID 19

  1061 Views

eMediNexus    29 June 2021

Severe acute respiratory syndrome coronavirus 2 is known to cause respiratory infection, which can be followed by severe systemic illness. Early use of Low dose (0.5–2 g/d) vitamin C has shown benefits in severe acute respiratory syndrome coronavirus 2 infections.

 

Cytokine storm involving interleukin-6 and endothelin-1, which causes Severe late forms of coronavirus disease 2019, have also observed to be benefitted/reduced by the use of Vitamin C (especially at high doses).

 

Vitamin C supplements are rendered cheap and safe, so can be used in a low dose as prophylaxis, and can be switched to (intravenous) high-dose in cases of severe COVID-19. 

To comment on this article,
create a free account.

Sign Up to instantly get access to 10000+ Articles & 1000+ Cases

Already registered?

Login Now

Most Popular Articles

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.